Key stats
Market capitalization
529.424MEGP
Dividends yield (FY)
15.60%
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
About CAIRO PHARMACEUTICALS
ISIN
EGS38391C016
Sector
Health Technology
Industry
Pharmaceuticals: Major
Website
kahira-pharma.com
CEO
Yasser Ahmed Farghaly Mohammad
Headquarters
Cairo
Founded
1962
Cairo Pharmaceuticals engages in the manufacture and distribution of pharmaceutical products for human and veterinary use, cosmetics and pesticides, and other chemical substances and related products. Its products include analgesics, antibiotics, antidepressants, antihistamines, dermatological, endocrine drugs, gastrointestinal drugs, ophthalmic, pulmonic, and urinary antiseptics. The company was founded in 1962 and is headquartered in Cairo, Egypt.
Income Statement
Balance Sheet
Cash Flow
Earnings
Next:—
0
Revenue
0